Preclinical Translational Research Unit

The Duke Preclinical Translational Research Unit (PTRU) provides:

  • Preclinical and translational research services, including cancer and non-cancer related applications that enable investigators (both inside and outside Duke) to conduct critical in vivo experiments.
  • Highly skilled input and oversight from Duke experts in cancer biology, pharmacokinetics, animal experimentation, medical devices, physiology, imaging, statistics, and regulatory support.
  • High-quality data documentation that delivers sound statistical design, clinical relevance, data integrity, efficient resource usage, and commercial viability.

For more information about PTRU, please visit their website.